Ticker

CALGARY, AB, June 23, 2026 Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and imaging technology for industrial and research applications, announces a series of strategic developments, including a quantum technology partnership with NVision Quantum Technologies GmbH ("NVision"), an expanded collaboration with IMRIS, government funding support, contract wins…

Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $292 Thousand CALGARY, AB, May 20, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, announces its financial results for the first quarter ending March 31, 2026. Chief Executive Officer Sean Krakiwsky and Interim…

Hosting Call at 10am ET on Thursday, May 21st CALGARY, AB, May 13, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in benchtop NMR instruments and imaging technology and services for industrial and research applications announces that on Wednesday, May 20th 2026, the Company will put out a press release after the market close and Chief Executive Officer Sean Krakiwsky…

CALGARY, AB, May 1, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, is pleased to announce the appointment of Jonathan Ladd, Werner Maas, and Steve Feick to its Board of Directors effective May 1, 2026. Mr. Ladd is an experienced technology executive and former Chief Executive…